Alpha Tribe
FeedCompaniesAgentsSubscribe

Filter announcements

  • All
  • Important
  • Results
  • Board Meeting
  • New Orders
  • QIP/Rights/Pref.
  • PPTs
  • JV/Acquisition
  • Insider Trade
  • Dividend/Bonus
  • Credit Ratings
  • Updates
  • Pledging
  • Investor Meet
  • Others

Download our app

Best experience on mobile

Get it on Google PlayDownload on the App Store

Join 5K+ users on Alpha Tribe

Loading...
Hester Biosciences Limited logo

Hester Biosciences Limited

HESTERBIO·Pharmaceuticals

Hester Biosciences Ltd is one of the leading animal health care companies & the second largest poultry vaccine manufacturer in India. Founded by Mr. Rajiv Gandhi in 1987, it has now a presence in over 30 countries & has a key market in India, Nepal & Tanzania. It has partnered with Bill & Melinda Gates Foundation, GALVmed, Golchha Organisation, Novapharma, etc. While operating across four broad verticals of Poultry…

126Announcements
04-09-2026Last filed
22Last 90 days

What Hester files

  • Others53
  • Investor Meet23
  • Updates22
  • Board Meeting11
  • Important7
  • Dividend/Bonus5
04-09-2026 · 01:30 pm

Shareholders approved reclassifying Mr. Ravin Gandhi (4.74%) and Ms. Bela Gandhi (4.71%) from Promoter to Public category. This reclassification changes their reporting status and enhances public float.

Read the full announcement→
PDF
04-09-2026 · 10:29 am

Hester Biosciences Limited has informed the Exchange regarding Proceedings of Postal Ballot. Further, the company has informed the Exchange regarding voting results along with copy of scrutinizers report together with copy of minutes.

Read the full announcement→
PDF
27-08-2026 · 07:28 pm

Hester Biosciences' bank facility ratings have been upgraded by CARE Ratings. Long-term facilities improved to CARE BBB+ (Stable) from BBB, while Long-term/Short-term facilities are now CARE BBB+ (Stable)/A2 from BBB (Stable)/A3+. Short-term facilities also moved to CARE A2 from A3+. This upgrade reflects the company's strong operational and financial performance...

Read the full announcement→
PDF
04-08-2026 · 07:29 pm

Hester Biosciences Limited has informed the Exchange regarding Notice of Postal Ballot

Read the full announcement→
PDF
01-08-2026 · 02:13 pm

Hester Biosciences reported strong Q1 FY27 standalone performance: revenue up 14%, PAT soared 88%, and EBITDA grew 95%. Gross margins improved from 69% to 78% due to product mix and efficiency. Consolidated revenue declined 8% impacted by Nepal and Africa, but profitability got a boost from the Gates Foundation reducing...

Read the full announcement→
PDF